Takeover threat is very possible while it is heavily discounted, but is not preferable when compared to organic growth in the long term, especially when considering the expandng use of the traetment in multiple liver tumours .
Hunter Halls $20-30 price prediction over the longer term appeals much more than a fast $12 takeover .
When considering that the longer term also will have dividends attatched, a takeover is just a big tax bill imo .
to all longtime holders and newbies, page-2
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $55.17M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.0¢ | $29.67K | 219.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 403968 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 155829 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
13.0¢ |
Change
-0.005 ( 1.89 %) |
||||
| Open | High | Low | Volume | ||
| 13.5¢ | 13.5¢ | 13.0¢ | 167497 | ||
| Last updated 15.58pm 14/06/2024 ? | |||||
| SRX (ASX) Chart |